A budget impact analysis of a digital monitoring solution in patients treated with oral anticancer agents: a medico-economic analysis of the randomized phase 3 CAPRI trial Etienne MinvielleHenri LeleuFlorian Scotté Original Paper 28 June 2024
The hidden cost of sophistication: economic complexity and obesity Ronald DjeunankanSosson TadadjeuUmmad Mazhar Original Paper 11 June 2024
Does medial tourism promote growth in healthcare sector? Hassan F. GholipourKourosh Esfandiar Original Paper Open access 06 June 2024
Population normative data for OxCAP-MH capability scores Péter György BalázsAgata ŁaszewskaValentin Brodszky Original Paper Open access 24 May 2024
Workload and short sickness absences in a cohort of Finnish hospital employees Tero KuusiMartti KulvikAnnina Ropponen OriginalPaper 23 May 2024
Monetary value of health—a practical decision-making framework combining equity considerations and WTP Elizabeta RibarićIsmar VelićAna Bobinac Original Paper 20 May 2024
Cost-effectiveness analysis of procalcitonin and lung ultrasonography guided antibiotic prescriptions in primary care Giulio CiscoArmando N. MeierJoachim Marti Original Paper Open access 18 May 2024
Long-term returns to local health-care spending Jakub ČervenýJan C. van Ours Original Paper Open access 18 May 2024
Costs associated with insufficient physical activity in Germany: cross-sectional results from the baseline examination of the German national cohort (NAKO) Sophie GottschalkHans-Helmut KönigJudith Dams Original Paper Open access 10 May 2024
Do institutions matter for citizens’ health status? Empirical evidence from Italy M. Alessandra AntonelliGiorgia Marini Original Paper Open access 09 May 2024
Is there a link between health care utilisation and subjective well-being? An exploratory study among older Danes Maiken Skovrider AaskovenTrine KjærDorte Gyrd-Hansen Original Paper Open access 08 May 2024
The impact of different perspectives on the cost-effectiveness of remote patient monitoring for patients with heart failure in different European countries Hamraz MokriPieter van BaalMaureen Rutten-van Mölken Original Paper Open access 03 May 2024
Map** functions for the PHQ-9 and GAD-7 to generate EQ-5D-3L for economic evaluation Clara MukuriaMatthew FranklinSebastian Hinde Original Paper Open access 25 April 2024
Economic assessment of abemaciclib for the adjuvant treatment of luminal HER2- breast cancer from the perspective of the Spanish health system Silvia Fenix-CaballeroAdrián Sanchez-VegasAntonio Olry de Labry Lima Original Paper 22 April 2024
Healthcare resource utilisation and direct medical cost for individuals with 5q spinal muscular atrophy in Sweden Thomas SejersenSophie GrahamAlex Simpson Original Paper Open access 20 April 2024
Economic evaluation of intensive home treatment in comparison to care as usual alongside a randomised controlled trial Ansam BarakatJurgen E. CornelisMatthijs Blankers Original Paper Open access 10 April 2024
The performance of the EQ-HWB-S as a measure of quality-of-life of caregivers in families that have experienced adverse events Cate BaileyKim DalzielTessa Peasgood Original Paper Open access 05 April 2024
Comparing GPs according to their model of practice: are multiprofessional group practices associated with more favourable working conditions? Myriam BiaisMatthieu CassouCarine Franc Original Paper 03 April 2024
Poverty, work intensity, and disability: evidence from European countries Chiara MussidaDario Sciulli Original Paper Open access 26 March 2024
Costs attributable to hypercholesterolemia in a single period and over the life cycle Stephanie ReitzingerMiriam ReissThomas Czypionka Original Paper Open access 22 March 2024
From test to rest: evaluating socioeconomic differences along the COVID-19 care pathway in the Netherlands Iris MeulmanEllen UitersNiek Stadhouders Original Paper Open access 18 March 2024
The EORTC QLU-C10D is a valid cancer-specific preference-based measure for cost-utility and health technology assessment in the Netherlands Micha J. PilzSimon SeyringerEva Maria Gamper Original Paper Open access 14 March 2024
Economic value of diastasis repair with the use of mesh compared to no intervention in Italy Carla RognoniAlessandro CarraraRosanna Tarricone Original Paper Open access 14 March 2024
Antivirals to prepare for surges in influenza cases: an economic evaluation of baloxavir marboxil for the Netherlands Simon van der PolMaarten J. PostmaCornelis Boersma Original Paper Open access 14 March 2024
The causal effect of early retirement on medication use across sex and occupation: evidence from Danish administrative data Jolien CremersTorben Heien NielsenClaus Thorn Ekstrøm Original Paper 13 March 2024
Cost awareness among intensivists in their daily clinical practice: a prospective multicentre study Timothée LehutCéline LambertAlexandre Lautrette Original Paper Open access 13 March 2024
Measurement properties of the EQ-5D-3L, EQ-5D-5L, and SF-6Dv2 in patients with late-onset Pompe disease Richard Huan XuNan LuoDong Dong Original Paper Open access 12 March 2024
What remains after the money ends? Evidence on whether admission reductions continued following the largest health and social care integration programme in England Vasudha WattalKatherine ChecklandMarcello Morciano Original Paper Open access 09 March 2024
Psychometric performance of EQ-5D-5L and SF-6Dv2 in patients with lymphoma in China Aixue Zhang**g LiPei Wang Original Paper 07 March 2024
Can redistribution of vaccine improve global welfare? Lessons from COVID-19 Gunjan KumariOindrila Dey Original Paper 29 February 2024
Preference-based utility weights for the Individualized Neuromuscular Quality of Life Questionnaire (INQoL), with a focus on non-dystrophic myotonia (NDM) Andrew LloydKim RandCrispin Ellis Original Paper Open access 28 February 2024
Assessment of health state utilities associated with adult and pediatric acid sphingomyelinase deficiency (ASMD) Louis S. MatzaKatie D. StewartRuth Pulikottil-Jacob Original Paper Open access 27 February 2024
The role of budget impact and its relationship with cost-effectiveness in reimbursement decisions on health technologies in the Netherlands Vivian Reckers-DroogJoost EnzingWerner Brouwer Original Paper Open access 27 February 2024
Systematic methodological review of health state values in glaucoma cost-utility analyses Kevin KennedyGurkaran SarohiaFeng **e Original Paper 27 February 2024
A principled approach to non-discrimination in cost-effectiveness Darius N. LakdawallaJason N. Doctor Original Paper Open access 27 February 2024
Measuring EQ-5D-5L utility values in parents who have experienced perinatal death Elizabeth M. CamachoKatherine J. GoldAlexander E. P. Heazell Original Paper Open access 25 February 2024
Unravelling risk selection in Spanish general government employee mutual funds: evidence from cancer hospitalizations in the public health network Jaime PinillaBeatriz G. López-ValcárcelEnrique Bernal-Delgado Original Paper Open access 20 February 2024
Validity and responsiveness of EQ-5D-Y in children with haematological malignancies and their caregivers Wen**g ZhouAnle ShenNan Luo Original Paper 14 February 2024
Comparing heuristic valuation processes between health state valuation from child and adult perspectives Stefan A. LipmanVivian T. Reckers-Droog Original Paper Open access 03 February 2024
A Spanish value set for the SF-6D based on the SF-12 v1 Jorge-Eduardo Martínez-PérezJosé-María Abellán-PerpiñánJuan-José Ruiz-López Original Paper Open access 01 February 2024
The Economic Costs of Informal Care: Estimates from a National Cross-Sectional Survey in The Netherlands Saif ElayanViola AngeliniAlice de Boer Original Paper Open access 31 January 2024
Pragmatic randomized controlled trial comparing a complex telemedicine-based intervention with usual care in patients with chronic conditions Susanna Sten-GahmbergKine PedersenBirgit Abelsen Original Paper Open access 31 January 2024
Screening strategy to advance HCV elimination in Italy: a cost-consequence analysis Andrea MarcellusiFrancesco Saverio MenniniPITER collaboration study group Original Paper 27 January 2024
AOTMiT reimbursement recommendations compared to other HTA agencies Aneta MelaDorota LisMaciej Niewada Original Paper Open access 23 January 2024
On spillovers in economic evaluations: definition, map** review and research agenda María J. Mendoza-JiménezJob van ExelWerner Brouwer Original Paper Open access 23 January 2024
A state-level analysis of macro-level factors associated with hospital readmissions Reginald A. SilverJoumana HaidarChandrika Johnson Original Paper 20 January 2024
Looking inside the lab: a systematic literature review of economic experiments in health service provision Massimo Finocchiaro CastroCalogero GuccioDomenica Romeo Original Paper Open access 11 January 2024
Cost-effectiveness of two online interventions supporting self-care for eczema for parents/carers and young people Tracey H. SachMary OnojaKim S. Thomas Original Paper Open access 09 January 2024
The impact of an ‘evergreening’ strategy nearing patent expiration on the uptake of biosimilars and public healthcare costs: a case study on the introduction of a second administration form of trastuzumab in The Netherlands Ghyli KirshnerPeter MakaiRon Kemp Original Paper Open access 08 January 2024
